1 Min Read
Oct 3 (Reuters) - PolarityTE Inc:
* PolarityTE Inc announces U.S. FDA registration of lead product SkinTE
* PolarityTE Inc says expects to accelerate commercialization of SkinTE in 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.